BioBright and Philips Collaborate on New AI to Improve the Patient and Clinician Experience
June 25 2019 - 8:00AM
Business Wire
BioBright, a data and analytics company unlocking the potential
of unstructured clinical and research information, today announced
an agreement with Royal Philips (NYSE: PHG; AEX: PHIA), a global
leader in health technology, to develop information solutions that
improve the patient and clinician experience across the healthcare
continuum. This development collaboration follows the participation
of BioBright in the Philips HealthWorks Startup Program in
Cambridge, MA.
Today’s healthcare systems are focused on the quadruple aim:
supporting population health in the communities they serve,
reducing costs, and improving the patient and clinician experience.
Successful systems continually strive to increase data usability,
streamline workflows, and find new ways to capture and deliver
important clinical insights in pursuit of these aims. By combining
leading-edge Philips solutions and over a century of healthcare
insights with BioBright’s secure voice and data processing
technologies, clinicians will have the ability to quickly input and
access the patient information they need to make informed care
decisions.
“Providing access to data sources in a secure manner that
respects patient privacy is still a challenge in healthcare today,”
said Charles Fracchia, CEO and founder of BioBright. “Working with
a market leader like Philips allows us to better understand these
complexities and how we can naturally integrate ambient information
into the clinical data environment. This lets us reduce
administrative burdens and cognitive demands while putting the
patient back at the center of healthcare.”
“Advances in technology have forced clinicians to spend more
time on data entry, toggling between disparate systems and chasing
down studies instead of focusing on the patient,” said Alberto
Prado, Head of Philips HealthWorks. “Our Philips HealthWorks
startup program allows us to collaborate with promising young
companies like BioBright and find ways to break down data silos,
integrating and processing large volumes of data from multiple
sources regardless of vendor. We can then present this data back in
a manner that makes sense for the clinician, allowing them to get
back to basics and giving them more time for human interaction with
their patients.”
BioBright is a privately owned data and analytics company in
Boston, MA, where it began operations in 2015. BioBright’s
technology enables biomedical companies to securely and privately
collect and analyze data at scale. Initially funded by DARPA, the
company is now deploying with leading equipment manufacturers and
biomedical companies, including four on the Fortune 500 list.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190625005147/en/
Charles Fracchia BioBright press@biobright.com +1 (617)
444-9007
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Apr 2023 to Apr 2024